Technology | Enterprise Imaging | March 20, 2017

Agfa HealthCare Releases Newest Version of Enterprise Imaging for Cardiology at ACC.17

Company also displayed early concept for collaboration with IBM Watson Health for automated structure reporting based on natural language processing and cognitive analytics

Agfa HealthCare, Enterprise Imaging for Cardiology, ACC.17, IBM Watson Health

March 20, 2017 — Agfa HealthCare announced the release a new version of its Enterprise Imaging for Cardiology platform at the American College of Cardiology ACC.17 expo, March 17-19 in Washington, D.C. Customer-driven enhancements include new structured reporting modules for congenital echocardiology and nuclear cardiology.

The suite is part of the Enterprise Imaging converged platform, which offers a care-centric workflow that is standards-based, improves interoperability and enables a comprehensive patient health record across departments within a single facility or between multiple facilities.

With Enterprise Imaging for Cardiology, cardiologists have a robust environment providing a single point of access to patient information from different sources. They can quickly retrieve a patient's complete cardiology file, generate a report and distribute it, all during one session, even from a remote location. Images, reports and relevant, sophisticated toolkits are supported by the task-based workflow that aligns with and supports their clinical workflow.

The new features provide support for congenital echocardiology and nuclear cardiology, deeply integrated into the Enterprise Imaging platform.

At ACC.17, Agfa HealthCare also showed an early concept for automated structured reporting based on natural language processing (NLP) and cognitive analytics, a work in progress in collaboration with IBM Watson Health. This collaboration illustrated how clinicians may be able to use normal dictation methods for reporting and still achieve structured report, as well as structured data using a natural language processing and cognition-based algorithm powered by IBM Watson, to convert dictated reports into structured data.

For more information: www.agfahealthcare.com

Related Content

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Overlay Init